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OBJECTIVES: The objectives of this study were to verify the degree of anxiety, respiratory distress, and health-related
quality of life in a group of asthmatic patients who have experienced previous panic attacks. Additionally, we
evaluated if a respiratory physiotherapy program (breathing retraining) improved both asthma and panic disorder
symptoms, resulting in an improvement in the health-related quality of life of asthmatics.
METHODS: Asthmatic individuals were assigned to a chest physiotherapy group that included a breathing retraining
program held once a week for three months or a paired control group that included a Subtle Touch program. All
patients were assessed using the Diagnostic and Statistical Manual of Mental Disorders IV, the Sheehan Anxiety
Scale, the Quality of Life Questionnaire, and spirometry parameter measurements.
RESULTS: Both groups had high marks for panic disorder and agoraphobia, which limited their quality of life. The
Breathing Retraining Group program improved the clinical control of asthma, reduced panic symptoms and
agoraphobia, decreased patient scores on the Sheehan Anxiety Scale, and improved their quality of life. Spirometry
parameters were unchanged.
CONCLUSION: Breathing retraining improves the clinical control of asthma and anxiety symptoms and the health-
related quality of life in asthmatic patients.
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INTRODUCTION
The relationship between asthma and anxiety is well-
established. Symptoms, such as respiratory discomfort, are
highly common in both panic disorder and in asthma. There
is evidence that breathing retraining helps to control the
symptoms of asthma and panic attacks with consequent
improvement in an asthmatic’s quality of life (1-3). However,
there is no strong evidence that a Chest Physiotherapy (CPT)
program, specifically the breathing retraining technique,
helps to reduce the symptoms of anxiety and improve
asthma control (1).
Asthma is a chronic inflammatory disorder of the airways
in which many different types of cellular elements play roles.
In susceptible individuals, this inflammation causes recur-
rent episodes of wheezing, breathlessness and coughing (4).
There is increasing recognition that psychological factors
influence the onset and course of asthma. Furthermore, there
is a significant correlation between asthma and negative
emotions, particularly anxiety and depression (2).
Anxiety is a very common illness, with a prevalence
estimated at up to 20% of the adult population. Anxiety has
demonstrated effects on indicators of quality of life (5).
Panic disorder and agoraphobia are among the many
anxiety disorders. Agoraphobia is the intense fear of finding
oneself in crowded places where there may be a perception
of difficulty to escape.
Previous cross-sectional community-based studies have
provided evidence for a relatively specific association
between the prevalence of asthma and panic disorder
(2,6). Both anxiety and depression are known to influence
the quality of life in asthmatics, and both put stress on the
health care system (3). A previous longitudinal study
showed that asthma increases the risk of panic, anxiety,
and depression (6). More complex models have described
asthma as an organic disease that is highly vulnerable to
psychological influences (7,8). Mood disorders were identi-
fied in 53% of asthmatic patients and in 34.9% of non-
asthmatics (9).
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According to the 2009 Physiotherapy Guidelines (12),
breathing retraining (as part of CPT) incorporates a reduction
in the respiratory rate and/or tidal volume with relaxation
training, which helps to control the symptoms of asthma and
is recommended as level 1++ scientific evidence (Grades A
and B). Breathing retraining includes instruction in pursed-
lip breathing and coordinated breathing with respiratory
exercises and has the added benefit of reducing anxiety and
stress (13).
Physiotherapists have advocated chest physiotherapy for
the management of breathing disorders (13,14). In a cohort
of asthmatics, a randomized controlled trial of breathing
retraining and relaxation led to a significant reduction in
respiratory symptoms and improvement in quality of life
(15). In another randomized controlled trial, asthmatic
patients trained in diaphragmatic breathing had clinically
relevant improvements in their quality of life, even nine
months after the intervention (16). Other studies (17,18)
reported effective reductions in the number of symptoms, the
frequency of attacks and degrees of depression and anxiety,
and improvements in respiratory parameters.
This study aimed to assess the degree of anxiety and
respiratory distress and the quality of life in a group of
asthmatic patients who have previously experienced panic
attacks. We also demonstrated that a respiratory physiother-
apy program (breathing retraining) may improve both asthma
and panic disorder symptoms, resulting in an improvement
in the health-related quality of life of asthmatics.
MATERIALS AND METHODS
Study design and eligibility
In this prospective study, we used specific and validated
methods for the quantification of anxiety symptoms in two
randomly selected samples of asthmatic patients from the
Asthma Clinic of the Pneumology Department of the
Hospital das Clı´nicas da Universidade de Sa˜o Paulo.
The study was approved by the Ethics Committee of the
institution, and informed written consent was obtained from
each patient. Asthmatic patients who had well-controlled
symptoms and received regular inhaled corticosteroids and
long-acting bronchodilators for at least one month were
included in the study according to the criteria of the Global
Initiative for Asthma (2). The inclusion criteria for the study
were: 1. at least three symptoms of panic and agoraphobia; 2.
persistent fear of public places or open areas or the need to be
removed from fear situations that trigger the crisis; and 3.
fulfillment of the criteria of asthma according to American
Thoracic Society (ATS).
All patients underwent a clinical exam and were evaluated
with the DSM-IV-R to establish panic and agoraphobia
symptoms, the Sheehan Anxiety Scale, the Quality of Life
questionnaire, forced vital capacity (FVC), forced expiratory
volume in one second (FEV1), forced expiratory flow 25-75%
(FEF 25-75%), and FEV1/FVC ratio (FEV1/FVC). Patients were
evaluated at the beginning of the study (Table 1 and Table 2) and
twelve weeks later [twice during the study (T = 0 and T = 12)].
Patients recorded daily symptoms/signs and rescue
salbutamol use in their diaries. The peak expiratory flow
rate (PEFR) was monitored with a portable device (Mini –
Wright, Clement Clark International, Harlow, Essex,
England) once a week for three months. Patient diaries
detailing symptoms and rescue salbutamol use were
collected at three months.
The Sheehan Disability Scale (19) is a three-item self-
reported scale that measures the severity of the disability in
the areas of work and family life, home responsibilities, and
social activities or hobbies. Each of these three areas is
scored on a Likert scale of ten points (a score of 0 is ‘‘not at
all impaired,’’ 5 is ‘‘moderately impaired’’ and 10 is ‘‘very
severely impaired’’). The scale provides a measurement of
total functional disability (range 0-30) and has been shown
to have appropriate internal reliability and validity (20). It
has previously been used in studies of panic disorder (21).
The Quality of Life questionnaire assesses an individual’s
well-being, complements traditional health and clinical mea-
sures, and captures the wider impact that asthma has on
physical, psychological, and social life. The specific instrument
we used for the determination of quality of life has been
validated for use in clinical trials (22). It assesses four domains:
activity limitation, symptoms, emotional function, and environ-
mental stimuli (22). The Quality of Life questionnaire assesses
physical limitation, the severity and frequency of symptoms,
adherence to treatment, and psychological factors.
Experimental groups
Thirty-eight asthmatic patients with a history of panic
symptoms entered this case-controlled study and were
randomly assigned (1:1 for two groups) to a breathing
retraining group (BRG, n = 20) or a control group that received
Subtle Touch (STG) (n = 18). The Subtle Touch technique
controls for the presence and the action of the physiotherapist
as potential confounding factors (Figure 1).
Exercise protocol
The same physiotherapist performed all of the physical
therapy maneuvers. The subjects were seen individually, once a
Table 1 - Preliminary patient demographic and
spirometry data for both the Breathing Retraining Group
(BRG) and the Subtle Touches group (STG). Eighty percent
of the BRG patients and 72.2% of the STG patients had
moderate/severe asthma. The BRG patients had a higher
frequency of previous smoking. Both groups had high
scores for panic disorder and agoraphobia, as indicated
by the appropriate scales. The BRG and the STG had the
same Daily Symptom Diary median scores.
Subject characteristics
Physiotherapy
(BRG) N = 20
Control
(STG) N = 18
Age, yr,
Mean¡SD 44.5 ¡11.5 41.5¡12.1
Sex
Male 03 03
Female 17 15
FEV1 % predicted 68.8¡21.5 66.5¡22.0
Mild asthma 20% (04/20) 27.8% (05/18)
Moderate asthma 50% (10/20) 50% (09/18)
Severe asthma 30% (06/20) 22.2% (04/18)
Current smoker 0 0
Past smoker 15% (3/20) 5.5% (1/18)
PD* 5.00 (4.00 – 6.00) 4.00 (3.00 – 4.00)
Sheehan 0.20¡0.16 0.27¡0.16
AG** 4.00 (3.00 – 4.00) 3.00 (3.00 – 4.00)
DSS*** 10.90¡6.30 10.90¡6.30
*PD = Panic disorder (median). ** AG = Agoraphobia (median).
*** DSS = Daily Symptom Scale (median)
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week, in an outpatient setting in which each patient underwent
a total of 30 minutes of Subtle Touch or breathing retraining.
Breathing retraining consists of six repetitions of each the
following physiotherapeutic exercises: 1. pursed-lip breathing
associated with a lying relaxed posture; 2. manual expiratory
passive therapy maneuvers; 3. diaphragmatic breathing; 4.
hiccup inspiratory maneuvers; 5. postural orientation; and 6.
twenty repetitions of Pompage (maneuvers performed for the
muscle fascia).
Subtle Touch, also called Calatonia, is a Jungian method
(23) that was developed by Petho Sandor, who demon-
strated that continued treatment with Subtle Touch
promotes the reduction of anxiety and depression and
leads to a stable mood. In this study, we used only the
physical aspects of Subtle Touch. This technique uses both
hands simultaneously on both sides of the thorax. The
Subtle Touch technique is performed in three steps: 1. a
gentle pressure is imposed on the skin with hands or
fingertips for three breaths, with a slow decompression
after the last one; 2. soft touches are performed during the
next three breaths; and 3. hands or fingertips maintain only
slight contact with the skin and remain still for three more
respiratory cycles.
Due to the limited sample size, a confidence interval of
95% and a maximum estimate error of 20% were used. A
control group (STG) was used to reduce sample limitations.
Statistical analysis
Statistical analysis was performed using Sigma Stat
software (Jandel Corp, San Rafael, CA). The data are
presented as means and standard deviations (SD) for age,
FEV1, and the Daily Symptom Scale. The scores for panic
disorder (PD), agoraphobia (AG), and Sheehan’s Disability
Scale are expressed as medians and ranges. The distribution
of asthma severity and the frequency of smoking are
expressed as percentages. All data were analyzed intra-
group and inter-group and were compared to the values at
the beginning and end of the study. A paired Student’s t-test
was used to compare the initial and final intra-group values.
One-way analysis of variance was used to compare the
experimental groups before and after experimental exercise.
Values of beta-2 agonist use, spirometry parameters and
peak flow were compared using a two-way analysis of
variance (ANOVA).
RESULTS
Table 1 summarizes the clinical and demographic data of
38 patients who completed the study. Forty-five patients
were initially recruited. Seven patients did not complete the
study; one died before randomization. Of the six remaining
patients who did not complete the study, four were in the
BRG. Three of these four patients did not attend all the
physiotherapy sessions, and one suffered an asthma
exacerbation. Two patients in the STG did not complete
the study. One of these two patients suffered an asthma
exacerbation, and the second patient did not attend all the
scheduled sessions (Figure 1).
The spirometry data from the beginning of the trial
revealed that, in both groups, the patients had values
indicative of moderate or severe asthma (Table 1). There
were no significant differences in spirometry measurements
(FVC, FEV1, FEF25-75%, FEV1/FVC) between the two
groups throughout the study. Interestingly, the peak flow
rate was significantly different between both groups.
We observed a progressive and significant increase in the
peak flow rate in the BRG (p#0.05); it remained stable with a
slight downward trend in the STG (Figure 3A). The use of a
b2 agonist (salbutamol) as a relief medication (Figure 3B)
decreased over time after the sixth week of the study, which
was significant for the BRG (p#0.05).
Patients from both groups had high levels of agoraphobia
and panic disorder at the start of the study. Statistically
significant reductions in panic disorder symptoms (accord-
ing to the DSM-IV-R) (p#0.05) and agoraphobia (p#0.05)
were observed only in the BRG (Figure 2A). There was no
difference in the same parameters when multiple analyses
were performed comparing the BRG with the STG. Panic
scores, according to the Sheehan scale, exhibited significant
decreases for both the BRG and the STG (p#0.05)
(Figure 2B).
Initially, the asthmatic patients who participated in this
study had substantial limitations in their quality of life, despite
receiving notably good clinical treatment and being consid-
ered stable. The variability in the Quality of Life questionnaire
occurred throughout the four domains (Table 2). Over the
course of multiple analyses, there were statistically significant
decreases in the values for the ‘‘physical limitation’’ domain
(p#0.05) and the ‘‘gravity/frequency’’ domain (p#0.05). There
was also an improvement in the psycho-social factors domain
Table 2 - The evolution of parameters expressed as median values (25%-75%). At the start of the study, both groups
presented with equally compromised health-related quality of life scores and the same levels of panic and asthma
symptoms. Final measurements indicated improvements in all domains.
Variations in the domains of quality of life and symptoms in asthmatic patients.
Group
Physiotherapy (BRG) (Before)
Median [25%-75%]
Physiotherapy ((BRG)
(After) Median [25%-75%]
Control (STG) (Before)
Median [25%-75%]
Control (STG) (After) Median
[25%-75%] p-value
VDAT 66.0 [99.8-48.9] 99.9 [99.9-4.1] 84.0 [99.8-48.6] 83.9 [99.8-66.0] *0.05
VDSF 6.7 [7.8-5.4] 3.7 [6.0-3.4] 6.6 [7.6-3.8] 4.5 [6.5-3.2] *0.012
VDPL 48.5 [52.0- 30.6] 18.0 [26.9-10.4] 49.6 [58.0-30.9] 26.3 [36.3-12.3] *0.001
VDP 36.0 [54.2-24.6] 54.9 [73.8-36.0] 35.9 [49.0-25.0] 48.9[62.0-36.0] *0.01
VDSE 49.9 [66.0-37.0] 75.3 [82.9-51.0] 49.9 [66.0-49.9] 49.7 [82.7-49.7] *0.01
PD 5.0 [6.0-4.2] 3.7 [5.0-1.1] 4.0 [4.0-3.2] 3.7 [4.0-3.0] *0.027
VDAT - Variation of the domain: adherence to treatment between groups; VDSF - Variation of the domain: severity/frequency between groups; VDPL -
Variation of the domain: physical limitation; VDP - Variation of the domain: psychosocial; VDSE - Variation of the domain: social-economic; VRS - range of
symptoms; PD - panic disorder. * Comparing the beginning of the experiments to the end of the protocol.
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for the two groups, although this improvement was not
statistically significant (p,0.01). At the end of the protocol, only
the BRG showed significant differences in the ‘‘adherence to
treatment’’ (p#0.05) and ‘‘social economic’’ (p#0.05) domains.
DISCUSSION
In this study, the three-month chest physiotherapy program
improved the clinical control of asthma and the quality of life and
decreased the symptoms of panic and agoraphobia in a group of
asthmatics with high anxiety scores at baseline. Spirometry
parameters remained unchanged, the daily peak flow values
increased and consumption of salbutamol decreased. The Subtle
Touch technique also led to improvements in these parameters,
but not to the same extent as breathing retraining.
Subjectively, the authors noted in their clinical experience
that episodes of breathlessness caused quality of life changes
in asthmatics, including a high attention deficit and a sense of
hopelessness regarding their disease prognosis. Additionally,
patients could learn about conscious control over breathing to
overcome psychological aspects. A review of the literature and
some existing publications on chest physiotherapy, anxiety,
and asthma revealed that there was a theoretical basis for a
more organized treatment approach.
Figure 1 - Study design.
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Patients enrolled in this study had symptoms of asthma
for more than twenty years; 76.3% had histories of
hospitalization during these years, and 34.2% had been in
an intensive care unit. All of the patients had high scores for
panic and agoraphobia. As was observed by other authors,
these data suggest that asthma severity can be associated
with anxiety and vice versa (24).
Some authors have sought to understand and clarify the
relationships between the respiratory system, mental state,
and personality (25,26). There are many reports and studies
linking anxiety disorders and depression to respiratory
dysfunction (5,26,27) and respiratory disorders in anxious
patients without lung disease (2,16).
A high level of psychiatric comorbidities was shown in
patients with severe asthma or difficult-to-control asthma
(28). Panic and fear are established risk factors for worse
asthma-related morbidity, independent of objective mea-
sures of pulmonary function (29). Generalized panic or fear
may affect the self-management of asthma by influencing
decisions about the use of rescue medication and the
avoidance of activities. The general tendency to respond
with anxiety to perceived threats in the environment (trait
anxiety) might lead patients to treat their emotional distress
with short-acting b2-agonists, particularly if they confuse
respiratory symptoms of anxiety for asthma (30). However,
excessive use of short-acting b2-agonists might also con-
tribute to greater levels of anxiety because of the side-effects
of these medications, such as tachycardia and tremor
(31,32). The association between generalized panic or fear
and avoidance of activities due to asthma may reflect
Figure 2 - At the end of the study, the scores for agoraphobia and panic disorder symptoms (Figure 2A) were significantly reduced only
in the BRG group (p,0.05). According to the Sheehan scale, panic scores (Figure 2B), were significantly decreased for both the BRG and
the STG (p,0.05). There were no differences in the same parameters when multiple analyses were performed comparing the BRG with
the STG.
Figure 3 - Weekly peak flow rate measurements (3A) and daily use of b2 agonist (3B) were monitored over three months. Peak flow rate
progressively and significantly increased in the BRG (p,0.05) but remained stable in the STG (Figure 3A). In the BRG, the use of b2
agonist (salbutamol) as a relief medication (Figure 3B) decreased over time, particularly after the sixth week (p,0.05).
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agoraphobic anticipation and may extend well beyond
adaptive aversion to asthma triggers (33).
This behavior may manifest as a greater demand for
health care, higher numbers of missed work and school
days, and increased morbidity and mortality rates. This
behavior can also result in the unnecessary use of
medications.
There are few reports that use chest physiotherapy and
relaxation techniques to control respiratory disease and
anxiety in asthmatics. The relationship between respiratory
and psychological disorders remains unclear.
A systematic review concluded that chest physiotherapy
may have some potential benefits (34). Two separate
randomized controlled trials of patients with asthma
demonstrated that chest physiotherapy and relaxation
significantly improved health-related quality of life and
identified significant reductions in asthma symptoms
(15,35). These results also call for further studies to
demonstrate the efficacy of breathing retraining on asthma
(36). In accordance with the literature, these new concepts in
asthma management should help reduce hospitalizations
and emergency room visits, increase adherence to treatment
and improve patient quality of life (37).
This study focused on non-pharmacological interventions
in addition to the recommended drug treatment for
controlling asthma. A breathing retraining program led to
a statistically significant effect in controlling symptoms of
anxiety and airway obstruction, with improvements in peak
flow rate and the use of lower amounts of salbutamol
without significant changes in the FEV1 of both groups. The
peak flow rate depends on the patient’s effort and the
strength and speed of expiratory muscle contraction.
Breathing retraining promotes biomechanical reorganiza-
tion and improves muscle function, which leads to a
significant improvement in peak flow independent of an
improvement in airway obstruction (22).
A control group (Subtle Touch) was introduced to reduce
possible confounding variables, such as the impact of a
therapist and the weekly contact with patients during visits.
Even in the Subtle Touch group, a generalized significant
improvement was observed. Subtle Touch treatment reduced
scores for panic disorder and agoraphobia, although to a
lesser degree than in the breathing retraining group.
Assuming that all patients were under optimal drug therapy,
the superior outcome observed for the BRG compared to the
STG is evidence for the benefits of breathing retraining to
control asthma and anxiety symptoms.
For the first time, we have demonstrated that the Subtle
Touch technique reduces the psychiatric symptoms associated
with asthma. These results are consistent with the hypothesis by
Sandor. Subtle Touch is a deep relaxation technique that leads
to the regulation of muscle tone and the promotion of physical
and psychological rebalancing of the patient. Essentially, Subtle
Touch therapy is performed by applying gentle stimuli in areas
of the body where there are particularly high concentrations of
nerve receptors. By promoting muscle relaxation, such techni-
ques may lead to improvements in respiratory muscle function.
According to the Jungian proposal, the Subtle Touch technique
works by reducing anxiety.
This study noted an increase in peak flow values and a
decrease in consumption of salbutamol for patients who
underwent physiotherapy. These results are consistent with
those of other studies (17) that show an effective reduction of
symptoms, frequency of attacks, and degree of depression
and anxiety with physical therapy. The benefits observed in
the twelve weeks of this study required observation for a
longer period of time and were consistent.
In conclusion, breathing retraining improves the clinical
control of asthma symptoms, anxiety symptoms, and the
health-related quality of life in asthmatics. In particular,
substantial benefits were observed in severely compromised
patients.
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